| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ac661be0b9a884290451af2b1432123 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
1988-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fefb22304291ed9d8f982ce102f901f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e15501e9103f8bfe729ecf279a2601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce4a5b64c4bbcbd024d1d4abdbf5b6e |
| publicationDate |
1995-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0284105-B1 |
| titleOfInvention |
Human manganese superoxide dismutase and methods of treatment |
| abstract |
There are disclosed a human manganese superoxide dismutase analog in which at least one of the human manganese superoxide dismutase polypeptides differs from naturally-occurring human manganese superoxide dismutase polypeptide by the absence of lysine at the N-terminus, and a human manganese superoxide dismutase analog in which at least one of the human manganese superoxide dismutase polypeptides differs from naturally-occurring human manganese superoxide dismutase polypeptide by the absence of both lysine and histidine at the N-terminus, pharmaceutical compositions comprising same in an amount effective to alleviate the undesirable symptoms associated with the generation of oxygen free radicals and a pharmaceutically acceptable carrier, as well as their use for the production of a pharmaceutical composition for alleviating the symtoms in a subject suffering from a disorder selected from synovial inflammation, arthritis and lung fibrosis. |
| priorityDate |
1987-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |